Lemaitre Vascular (LMAT) Asset Utilization Ratio (2011 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Asset Utilization Ratio of 0.41 for Q1 2026, up 0.77% year-over-year from 0.41 in Q1 2025, and little changed quarter-over-quarter from 0.41 in Q4 2025.
Lemaitre Vascular (LMAT) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Asset Utilization Ratio for 16 consecutive years, with 0.41 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 0.77% year-over-year to 0.41; the TTM figure through Mar 2026 stood at 0.41 (up 0.77% YoY), while the FY2025 annual figure was 0.43, down 12.62% from the prior year.
- Asset Utilization Ratio held at 0.41 in Q1 2026 per LMAT's latest filing, from 0.41 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.58 in Q3 2024 and bottomed at 0.41 in Q1 2025.
- Historically, Asset Utilization Ratio has averaged 0.51 across 5 years, with a median of 0.54 in 2022.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio gained 7.69% — and 2025, when it retreated 28.82%.
- Lemaitre Vascular's Asset Utilization Ratio stood at 0.53 in 2022, then climbed by 7.69% to 0.57 in 2023, then decreased by 16.71% to 0.47 in 2024, then retreated by 13.12% to 0.41 in 2025, then advanced by 0.08% to 0.41 in 2026.
- Business Quant data shows LMAT's Asset Utilization Ratio at 0.41 in Q1 2026, 0.41 in Q4 2025, and 0.41 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 0.54 |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 0.46 |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 0.34 |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 0.64 |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 0.73 |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 0.81 |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 0.59 |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 0.34 |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 0.56 |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | 0.41 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.41 |
| Mar 31, 2026 | 0.41 |
| Dec 31, 2025 | 0.41 |
| Sep 30, 2025 | 0.41 |
| Jun 30, 2025 | 0.41 |
| Mar 31, 2025 | 0.41 |
| Dec 31, 2024 | 0.47 |
| Sep 30, 2024 | 0.58 |
| Jun 30, 2024 | 0.57 |
| Mar 31, 2024 | 0.57 |
| Dec 31, 2023 | 0.57 |
| Sep 30, 2023 | 0.56 |
| Jun 30, 2023 | 0.55 |
| Mar 31, 2023 | 0.54 |
| Dec 31, 2022 | 0.53 |
| Sep 30, 2022 | 0.53 |
| Jun 30, 2022 | 0.54 |
| Mar 31, 2022 | 0.54 |
| Dec 31, 2021 | 0.53 |
| Sep 30, 2021 | 0.57 |